Inizio
Inizio, a leading global healthcare services company, is headquartered in London, UK, with significant operations across North America and Europe. Founded in 2021, Inizio has quickly established itself in the healthcare industry, focusing on areas such as medical communications, commercialisation, and patient engagement. The company offers a unique suite of services designed to enhance the effectiveness of healthcare brands and improve patient outcomes. With a commitment to innovation and excellence, Inizio has achieved notable milestones, including rapid growth and strategic partnerships that bolster its market position. As a trusted partner for pharmaceutical and biotech companies, Inizio continues to set benchmarks in delivering tailored solutions that meet the evolving needs of the healthcare landscape.
DitchCarbon Score
How does Inizio's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Instruments industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Inizio's score of 53 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Inizio's reported carbon emissions
Inizio Group Limited has made significant strides in addressing its carbon emissions, with the most recent data from 2023 indicating total emissions of approximately 38.1 million tonnes CO2e. This figure includes about 5.9 million tonnes CO2e from Scope 1 emissions, 1.9 million tonnes CO2e from Scope 2, and a substantial 30.2 million tonnes CO2e from Scope 3 emissions. The company has set ambitious reduction targets, committing to a 46.2% reduction in absolute Scope 1 and 2 greenhouse gas emissions by 2031, using 2021 as the baseline year. Additionally, Inizio aims to reduce its Scope 3 emissions—specifically from purchased goods and services, fuel- and energy-related activities, and business travel—by 27.5% within the same timeframe. Inizio's climate commitments align with industry standards, as they have pledged to achieve net-zero emissions by 2050. Their targets are consistent with the reductions necessary to limit global warming to 1.5°C, demonstrating a proactive approach to climate action in the pharmaceuticals, biotechnology, and life sciences sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project2019 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 22,734,000 | 0,000,000 | 00,000,000 | 0,000,000 |
| Scope 2 | 11,122,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 1,173,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Inizio is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
